---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-26-000094"
form_type: "8-K"
ticker: "PTHS"
cik: "0001919246"
company_name: "Pelthos Therapeutics Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:57:41.966964+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "medium"
source: SEC EDGAR
---

# Pelthos Therapeutics revises non-employee director compensation, increases Chairman cash retainer to $60k

## Summary
- Non-Executive Chairman annual cash retainer increased from $50k to $60k, effective January 1, 2026.
- New annual cash retainers for committee service: Audit Chair $19k, Compensation Chair $15k, Nominating Chair $12k.
- Board member annual cash retainer unchanged at $40k; no annual equity grants to non-employee directors.
- Changes based on compensation committee assessment to align with peer group practices.

## SEC filing metadata
- accession: 0001753926-26-000094
- form_type: 8-K
- ticker: PTHS
- cik: 0001919246
- company_name: Pelthos Therapeutics Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: medium
- sec_items: 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000175392626000094/0001753926-26-000094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1919246/000175392626000094/g085077_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-26-000094
- JSON: https://secwatch.observer/filing/0001753926-26-000094.json
- Plain text: https://secwatch.observer/filing/0001753926-26-000094.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.